DK1067934T3 - Flydende oral opløsning omfattende det anti-depressive middel mirtazapin - Google Patents

Flydende oral opløsning omfattende det anti-depressive middel mirtazapin

Info

Publication number
DK1067934T3
DK1067934T3 DK99917956T DK99917956T DK1067934T3 DK 1067934 T3 DK1067934 T3 DK 1067934T3 DK 99917956 T DK99917956 T DK 99917956T DK 99917956 T DK99917956 T DK 99917956T DK 1067934 T3 DK1067934 T3 DK 1067934T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
oral solution
liquid oral
antidepressant mirtazapine
antidepressant
Prior art date
Application number
DK99917956T
Other languages
Danish (da)
English (en)
Inventor
Arnold Titus Philip Skrabanja
Roger Edward Tully
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1067934T3 publication Critical patent/DK1067934T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
DK99917956T 1998-04-02 1999-03-29 Flydende oral opløsning omfattende det anti-depressive middel mirtazapin DK1067934T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201037 1998-04-02
PCT/EP1999/002277 WO1999051237A1 (en) 1998-04-02 1999-03-29 Oral liquid antidepressant solution

Publications (1)

Publication Number Publication Date
DK1067934T3 true DK1067934T3 (da) 2004-03-29

Family

ID=8233550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99917956T DK1067934T3 (da) 1998-04-02 1999-03-29 Flydende oral opløsning omfattende det anti-depressive middel mirtazapin

Country Status (12)

Country Link
US (2) US6040301A (de)
EP (1) EP1067934B1 (de)
AT (1) ATE254918T1 (de)
AU (1) AU747975B2 (de)
BR (1) BR9909357A (de)
CA (1) CA2326356C (de)
DE (1) DE69913116T2 (de)
DK (1) DK1067934T3 (de)
ES (1) ES2212550T3 (de)
HK (1) HK1032012A1 (de)
PT (1) PT1067934E (de)
WO (1) WO1999051237A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
WO2002064735A2 (en) * 2001-02-12 2002-08-22 Akzo Nobel N.V. Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
WO2006031720A2 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
JP2008519055A (ja) * 2004-11-08 2008-06-05 シャイア エルエルシー ミルタザピンと興奮剤複合物の併用投与の相乗効果
TW200631584A (en) * 2004-11-15 2006-09-16 Akzo Nobel Nv A medicament related to mirtazapine for the treatment of hot flush
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
EP2567069A4 (de) 2010-05-05 2014-04-16 Ener G Rotors Inc Fluidische energieübertragungsvorrichtung
US8714951B2 (en) * 2011-08-05 2014-05-06 Ener-G-Rotors, Inc. Fluid energy transfer device
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
ATE99943T1 (de) * 1989-12-06 1994-01-15 Akzo Nv Psychotropische wirkstoffe enthaltende stabilisierte loesungen.
US5208261A (en) * 1989-12-06 1993-05-04 Akzo N.V. Stabilized solutions of psychotropic agents
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
US5238699A (en) * 1991-11-27 1993-08-24 Kraft General Foods, Inc. Ready-to-eat, low/no-fat puddings and process

Also Published As

Publication number Publication date
EP1067934A1 (de) 2001-01-17
CA2326356C (en) 2008-06-03
WO1999051237A1 (en) 1999-10-14
HK1032012A1 (en) 2001-07-06
DE69913116T2 (de) 2004-06-03
ATE254918T1 (de) 2003-12-15
BR9909357A (pt) 2000-12-12
AU3604899A (en) 1999-10-25
CA2326356A1 (en) 1999-10-14
PT1067934E (pt) 2004-03-31
ES2212550T3 (es) 2004-07-16
US6040301A (en) 2000-03-21
US6114324A (en) 2000-09-05
DE69913116D1 (de) 2004-01-08
EP1067934B1 (de) 2003-11-26
AU747975B2 (en) 2002-05-30

Similar Documents

Publication Publication Date Title
DK1067934T3 (da) Flydende oral opløsning omfattende det anti-depressive middel mirtazapin
YU84703A (sh) Oralni rastvor aripiprazola
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0209579A (pt) Derivados de 2-piridina ciclohexana-1, 4 diamina substituìdos
BR9906758A (pt) Método e composição para transferir zinco para a membrana nasal
WO2000002542A3 (de) Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum
BR9804437A (pt) Compostos para a osteoporose
RS50360B (sr) Farmaceutske formulacije derivata platine
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DK0675717T3 (da) Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin
ATE249205T1 (de) Wässrige suspension zur nasalen verabreichung von loteprednol
BR0105563A (pt) Derivados e análogos de galantamina
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
NO973589L (no) Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
BR9812982A (pt) Agente anti-reumático
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
BR0114459A (pt) Derivados substituìdos de 5-amino-1-penten-3-ol substituidos
HUP0300191A2 (hu) 2,6-Diamino-6-metil-heptánsav és származékai, eljárás ezek előállítására és alkalmazásuk